Genedrive PLC (GB:GDR)
LSE:GDR
Holding GB:GDR?
Track your performance easily

Genedrive (GDR) Share Price & Analysis

27 Followers

GDR Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

1.15%98.85%
― Other Institutional Investors
98.85% Public Companies and
Individual Investors

GDR FAQ

What was Genedrive PLC’s price range in the past 12 months?
Genedrive PLC lowest share price was 1.21p and its highest was 9.84p in the past 12 months.
    What is Genedrive PLC’s market cap?
    Currently, no data Available
    When is Genedrive PLC’s upcoming earnings report date?
    Genedrive PLC’s upcoming earnings report date is Nov 19, 2024 which is in 9 days.
      How were Genedrive PLC’s earnings last quarter?
      Genedrive PLC released its earnings results on Mar 28, 2024. The company reported -0.016p earnings per share for the quarter, missing the consensus estimate of N/A by -0.016p.
        Is Genedrive PLC overvalued?
        According to Wall Street analysts Genedrive PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Genedrive PLC pay dividends?
          Genedrive PLC does not currently pay dividends.
          What is Genedrive PLC’s EPS estimate?
          Genedrive PLC’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Genedrive PLC have?
          Genedrive PLC has 543,141,500 shares outstanding.
            What happened to Genedrive PLC’s price movement after its last earnings report?
            Genedrive PLC reported an EPS of -0.016p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.846%.
              Which hedge fund is a major shareholder of Genedrive PLC?
              Currently, no hedge funds are holding shares in GB:GDR
              ---

              Company Description

              Genedrive PLC

              Genedrive PLC is a holding company engaged in molecular diagnostics business. It operates in one operating segment named as Diagnostics which is engaged in Genedrive Point of need molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. Geographically the majority of the revenue is derived from the United States of America.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Allergy Therapeutics
              N4 Pharma
              EKF Diagnostics Holdings
              Verici Dx Plc
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis